One of the major unsolved problems with the gene-editing technology CRISPR/Cas9 is that it can cleave at off-target sites. Now, researchers from the Broad Institute were able to reduce off-target DNA cutting by replacing three amino acids in the Cas9 protein that cuts DNA.